Home/Filings/4/0001013762-25-004330
4//SEC Filing

M33 Growth I L.P. 4

Accession 0001013762-25-004330

CIK 0001799191other

Filed

Mar 27, 8:00 PM ET

Accepted

Mar 28, 7:36 PM ET

Size

10.2 KB

Accession

0001013762-25-004330

Insider Transaction Report

Form 4
Period: 2025-03-26
M33 Growth I L.P.
Director10% Owner
Transactions
  • Award

    Warrant to Purchase Shares of Common Stock

    2025-03-26$0.13/sh+1,358,449$169,8061,358,449 total
    Exercise: $1.20From: 2025-03-26Exp: 2030-03-26Common Stock (1,358,449 underlying)
  • Award

    Common Stock

    2025-03-26$1.04/sh+2,716,898$2,830,19316,420,701 total
M33 Growth I GP LLC
Director10% Owner
Transactions
  • Award

    Warrant to Purchase Shares of Common Stock

    2025-03-26$0.13/sh+1,358,449$169,8061,358,449 total
    Exercise: $1.20From: 2025-03-26Exp: 2030-03-26Common Stock (1,358,449 underlying)
  • Award

    Common Stock

    2025-03-26$1.04/sh+2,716,898$2,830,19316,420,701 total
Footnotes (2)
  • [F1]On March 26, 2025, pursuant to a Securities Purchase Agreement, dated March 24, 2025, M33 Growth I LP ("M33 LP") purchased an aggregate of 1,358,449 units ("Units") consisting of 2,716,898 shares of common stock and 1,358,449 warrants ("Warrants") to purchase shares of common stock for an exercise price of $1.1980 per share. M33 acquired the Units for a price per Unit of $2.2084 (an aggregate purchase price of $2,999,998.77), with a cost per share of common stock of $1.0417 and a cost per Warrant of $0.1250. The Warrants are not exercisable to the extent that the exercise thereof would cause the reporting person to beneficially own greater than 19.99% of the outstanding shares of common stock of the Issuer. The purchase of the Units was approved by the Issuer's Board of Directors in accordance with Rule 16b-3 under the Securities Exchange Act of 1934, as amended.
  • [F2]M33 Growth I GP LLC ("M33 LLC") is the general partner of M33 LP ("M33 GP") and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein.

Documents

1 file

Issuer

Oncology Institute, Inc.

CIK 0001799191

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001718621

Filing Metadata

Form type
4
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 7:36 PM ET
Size
10.2 KB